der in health, hygiene and home, listed on in the top 25 on the London Stock Exchange (LSE). With a purpose of delivering innovative solutions for healthier lives and happier homes, RB has more trebled revenues since it was formed in 2000 and its market cap has more than quadrupled. Today it is the global No 1 or No 2 in the majority of its fast-growing categories, driven by an exceptional rate of innovation. Its health, hygiene and home portfolio is led by 19 global Powerbrands including in the over the counter health category Mucinex, Durex, Nurofen, Strepsils Gaviscon and Scholl, and in the hygiene category Lysol, Dettol, Clearasil, Veet, Harpic, Bang, Mortein and Finish.
RB people and its culture are at the heart of the company's success. They have an intense drive for achievement and a desire to outperform wherever they focus, including in CSR where the company has reduced its carbon footprint by 20% in 5 years and is now targeting to deliver a 1/3 reduction in water use, 1/3 further reduction in carbon and have 1/3 of its net revenue coming from more sustainable products by 2020. It is also the Save the Children charity's largest FMCG global partner.
The company has operations in over 60 countries, with headquarters in the UK, Singapore, Dubai and Amsterdam, and sales in almost 200 countries. The Company employs approximately 38,000 people worldwide.
For more information visit www.rb.com
About Schiff
Schiff's vitamin, minerals and supplements (VMS) product portfolio includes a number of market leading brands in the specialist product category in the USA, including MegaRed®, number 1 in the healthy heart segment, Move Free® the number 2 in joint care, Airborne® the number 2 in immune support, and Schiff Vitamins®.
Forward-Looking Statements
Statements herein regarding the proposed transaction between Reckitt Benckiser and Schiff, future finan
'/>"/>
SOURCE Reckitt Benckiser Group PLC Copyright©2012 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 Related medicine technology :1.
Colorado Telehealth Network Signs Contract with GNAX Health to Provide Statewide Medical Image Archive and Exchange2.
Medisafe 1 Technologies Signs the $7MM Perpetual License Agreement3.
TNI BioTech, Inc. Signs Exclusive Distributor Agreement for Federal Republic of Nigeria with G-Ex Technologies/St. Maris Pharma & GB Pharma Holdings LLC4.
HealthTrust Purchasing Group Signs Renewal for GHX Solutions to Continue Supply Chain Cost Reductions5.
QUANTEL Medical Signs Global Licensing Agreement with IRIDEX6.
PDI Signs Agreement with HealthTrust for Surface Disinfection Products7.
Cincinnati based Radiology Group signs with Comprehensive Medical Practice Management8.
Projecis Signs "Top 5" Worldwide Generic Drug Maker and Niche European CRO as Sales Climb for Software Company9.
Henry Schein Signs Agreement To Expand Animal Health Presence To Ireland With The Acquisition Of C&M Vetlink10.
Parker Signs Licensing Agreement with Vanderbilt for Exoskeleton Technology and Targets Commercial Launch in 201411.
Varian Medical Systems Signs Purchase Agreement with Advanced Particle Therapy LLC to Supply Technology for the Georgia Proton Treatment Center to be operated by Emory Healthcare